Fierce Pharma

Tuesday, the U.S. regulator greenlit GSK’s depemokimab, an ultra-long-acting biologic, [...]

As both Novo Nordisk and Eli Lilly race to develop [...]

The FDA has approved Enhertu combined with Roche’s Perjeta as [...]

The FDA has signed off on Milestone Pharmaceuticals’ Cardamyst, a [...]

After three decades of no new antibiotics for the treatment [...]

The CDC findings were released as the FDA considers placing [...]

GSK’s depemokimab, a long-acting biologic that’s key to the British [...]

As it shifts strategic direction to prioritize its recently acquired [...]

Thursday, the FDA greenlighted Uplizna to treat generalized myasthenia gravis [...]

With an increase in the antimicrobial resistance to therapies for [...]